Bernardo-Seisdedos, G.; Charco, J.M.; SanJuan, I.; García-Martínez, S.; Urquiza, P.; Eraña, H.; Castilla, J.; Millet, O.
Improving the Pharmacological Properties of Ciclopirox for Its Use in Congenital Erythropoietic Porphyria. J. Pers. Med. 2021, 11, 485.
https://doi.org/10.3390/jpm11060485
AMA Style
Bernardo-Seisdedos G, Charco JM, SanJuan I, García-Martínez S, Urquiza P, Eraña H, Castilla J, Millet O.
Improving the Pharmacological Properties of Ciclopirox for Its Use in Congenital Erythropoietic Porphyria. Journal of Personalized Medicine. 2021; 11(6):485.
https://doi.org/10.3390/jpm11060485
Chicago/Turabian Style
Bernardo-Seisdedos, Ganeko, Jorge M. Charco, Itxaso SanJuan, Sandra García-Martínez, Pedro Urquiza, Hasier Eraña, Joaquín Castilla, and Oscar Millet.
2021. "Improving the Pharmacological Properties of Ciclopirox for Its Use in Congenital Erythropoietic Porphyria" Journal of Personalized Medicine 11, no. 6: 485.
https://doi.org/10.3390/jpm11060485
APA Style
Bernardo-Seisdedos, G., Charco, J. M., SanJuan, I., García-Martínez, S., Urquiza, P., Eraña, H., Castilla, J., & Millet, O.
(2021). Improving the Pharmacological Properties of Ciclopirox for Its Use in Congenital Erythropoietic Porphyria. Journal of Personalized Medicine, 11(6), 485.
https://doi.org/10.3390/jpm11060485